Global Markets and Technologies for Medical Lasers: Focus on the U.S. and Canada

2012-01-12
Published : Jan-2012

Report Summary

  • The global market for medical laser devices was $2.7 billion in 2010. As it recovers from the effects of the recent recession, the market is expected to increase to more than $3 billion in 2011 and nearly $6.8 billion in 2016, a compound annual growth rate (CAGR) of 17.3% over the 5-year period.
  • The U.S. and Canadian market for medical lasers was worth nearly $1.5 billion in 2010. In 2011, the market is projected to approach $1.7 billion and, by 2016, it should be nearly $3.9 billion, a CAGR of 18.1% between 2011 and 2016.
  • The combined U.S. and Canadian market for diagnostic and therapeutic ophthalmic lasers was worth $731 million in 2010. Diagnostic lasers accounted for about 55% of this market. In 2011, the market is projected to approach $867 million and, by 2016, it should be nearly $2.4 billion, a CAGR of 22.7% between 2011 and 2016.

GOALS AND OBJECTIVES

The market for medical lasers, in other words, is in a period of considerable flux. This report is an update of an earlier BCC report published in 2009. The overall goal of this study is to provide the reader with an up-to-date understanding of the technological, economic, and regulatory forces that are influencing the future size and structure of the market for medical lasers. Specific objectives include the following:

  • Identifying the medical laser technologies and applications with the greatest commercial potential in the near to mid-term (2010–2016)
  • Analyzing the key drivers and constraints that will shape the market for medical lasers over the next 5 years
  • Estimating the current and future demand for medical lasers through 2016. Ascertaining which companies are best positioned to meet this demand, because of proprietary technologies, strategic alliances, or other advantages.

INTENDED AUDIENCE

The report is intended especially for vendors of medical lasers, as well as government agencies, healthcare policy analysts, and others seeking to understand the medical applications of laser technologies. Although the report focuses on specific technologies, it is largely nontechnical in nature. That is, it is concerned less with theory and jargon than with what works, how much of the latter the market is likely to purchase, and at what price.

As such, the report’s main audience is executive management, marketing, and financial analysts. It is not written specifically for scientists and technologists, although its findings concerned the market for their work, including the availability of government and corporate research funding for different technologies and applications should interest them as well.

SCOPE AND FORMAT

The report addresses the global market for lasers used in diagnostic, therapeutic, and cosmetic applications during the period from 2010 through 2016. It addresses the market in its entirety as well as in selected regional and country markets.

The report does not cover the market for lasers used in the fabrication of medical devices (e.g., in the creation of microscopic features and spot welds). The focus is on the market for lasers themselves, rather than the larger pieces of equipment that incorporate them.

The format of the study includes the following elements:

  • Summary
  • Definitions
  • Types of medical lasers and their main applications
  • End-user segments
  • Market environment (legal and regulatory, standards, trends in the healthcare industry, demographic and economic trends, other market drivers and barriers to deployment)
  • Detailed market estimates and projections, by type of laser/end-user segment/geographical area for the period 2010–2016
  • Supplier profiles
  • Patent analysis.

Medical Lasers Market

Published: January 2012
No.OF Pages: 144
Price: Single User License – US$ 3900      Corporate User License US$ 6835

Table Of Contents

Chapter- 1: INTRODUCTION – Complimentary  5
STUDY BACKGROUND
GOALS AND OBJECTIVES
INTENDED AUDIENCE
SCOPE AND FORMAT
METHODOLOGY
AUTHOR’S CREDENTIALS
RELATED BCC RESEARCH
BCC ON-LINE SERVICES
DISCLAIMER

Chapter- 2: SUMMARY 2
Table: GLOBAL MARKET FOR MEDICAL LASERS BY END USE, THROUGH 2016
Figure: GLOBAL MARKET FOR MEDICAL LASERS BY END USE, THROUGH 2016

Chapter- 3: OVERVIEW OF MEDICAL LASERS 9
BASIC CONCEPTS
HISTORY OF MEDICAL LASERS
EFFECTS OF LASERS ON HUMAN TISSUE
MEDICAL TREATMENTS USING LASERS
Table: COMMON TYPES OF MEDICAL LASER TREATMENTS

Chapter- 4: INTELLECTUAL PROPERTY 6
Figure: U.S. MEDICAL LASER PATENTS ISSUED SINCE 1976 AND PATENT APPLICATIONS PENDING AS OF 10/29/2011
Figure: U.S. MEDICAL LASER PATENT TRENDS OVER TIME, <2007-2011
Figure: U.S. MEDICAL LASER PATENT APPLICATION TRENDS OVER TIME, <2007-2011
Figure: MAJOR U.S. PATENT PORTFOLIOS RELATING TO MEDICAL LASERS
Figure: U.S. MEDICAL LASER PATENTS BY INVENTOR/ASSIGNEE’S COUNTRY

Chapter- 5: OPHTHALMIC LASERS 10
APPLICATIONS AND TECHNOLOGIES
SUPPLIERS
Table: SUPPLIERS OF OPHTHALMIC LASERS

Chapter- 6: SURGICAL LASERS 15
APPLICATIONS AND TECHNOLOGIES
SUPPLIERS
Table: SUPPLIERS OF SURGICAL LASERS

Chapter- 7: COSMETIC LASERS 9
APPLICATIONS AND TECHNOLOGIES
SUPPLIERS
Table: SUPPLIERS OF COSMETIC LASERS
Figure: GLOBAL COSMETIC LASER MARKET SHARES, 2010

Chapter- 8: DENTAL LASERS 7
APPLICATIONS AND TECHNOLOGIES
SUPPLIERS
Table: SUPPLIERS OF DENTAL LASERS

Chapter- 9: VETERINARY LASERS 2
APPLICATIONS AND TECHNOLOGIES
SUPPLIERS
Table: SUPPLIERS OF VETERINARY LASERS

Chapter- 10: GOVERNMENT REGULATION 10
UNITED STATES
CANADA
EUROPEAN UNION
JAPAN
CHINA
INDIA
OTHER COUNTRIES

Chapter- 11: GLOBAL MARKET FOR MEDICAL LASERS, 2010–2016 9
OVERALL MARKET SIZE
END-USE SEGMENTS
APPLICATION SEGMENTS
TECHNOLOGY SEGMENTS
GEOGRAPHICAL SEGMENTS
Table: GLOBAL MARKET FOR MEDICAL LASERS BY REGION, THROUGH 2016
Figure: GLOBAL MEDICAL LASER GEOGRAPHICAL SEGMENTS

Chapter- 12: U.S. AND CANADIAN MARKETS FOR MEDICAL LASERS, 2010–2016 43
SUMMARY
OPHTHALMIC LASERS
SURGICAL
COSMETIC
DENTAL
VETERINARY

Chapter- 13: COMPANY PROFILES 17
ABBOTT MEDICAL OPTICS
AESCULIGHT, LLC
ALCON, INC.
ANGIODYNAMICS, INC.
ASUKA LASER SYSTEMS, INC.
BIOLASE TECHNOLOGY, INC.
BIOLITEC AG
CANDELA CORP.
COHERENT, INC.
CONVERGENT LASER TECHNOLOGIES
CYNOSURE, INC.
DEKA LASER
DENFOTEX LIGHT SYSTEMS, LTD.
DORNIER MEDTECH GMBH
ELLEX MEDICAL LASERS, LTD.
ERCHONIA MEDICAL
HEIDELBERG ENGINEERING
IRIDEX CORP.
LANTIS LASER, INC.
LISA LASER PRODUCTS
LUMENIS, LTD.
NIDEK COMPANY, LTD.
ONDINE BIOPHARMA CORP.
OPTOS, PLC
PALOMAR MEDICAL TECHNOLOGIES, INC.
PARALLAX TECHNOLOGY, INC.
PHOTOMEDEX
PLC SYSTEMS, INC.
QUANTEL MEDICAL
SOLTA MEDICAL, INC.
SPECTRANETICS CORP.
TRIA BEAUTY, INC.
TRIMEDYNE, INC.
VASCULAR SOLUTIONS, INC.
CARL ZEISS MEDITEC AG
WORLD OF MEDICINE AG

List of Tables and Figures

Filed in: Pharmaceuticals and Healthcare
Tags: 
More Reports
Title Price Buy Now

Ambulatory EHR Market by Delivery Mode (Cloud-based, On-premise), Application (e-Prescribing, PHM, Health Analytics, Practice, Patient & Referral Management), Practice Size (Large, Small-to-Medium, Solo), End User (Independent) – Global Forecast to 2027

“The ambulatory EHR market is projected to grow at a CAGR of 6.1% between 2022 and 2027.” The global ambulatory EHR market is projected to reach USD 5.7 billion in 2022 to USD 7.7 billion by 2027, at a CAGR of 6.1%during the forecast period. Growth in this market is driven by the opportunities provided by the market such as increasing demand for cloud-based ambulatory EHR market, and shift towards patient-centric healthcare delivery. However, the interoperability issues & data security concerns are some of the challenges that are expected to limit the growth of the market to a certain extent during the forecast period. “Cloud-based was the fastest-growing segment in the delivery mode of ambulatory EHR market in 2021” Cloud-based segment is projected to growth at the hi......
 $4950

Topical Drug Delivery Market by Type (Semi-solids (Creams, Gels, Lotions), Solids(Suppositories), Liquids(Solutions), Transdermal products), Route(Dermal, Ophthalmic), Facility of Use (Homecare setting, Hospitals, Burn Centres) – Global Forecast to 2027

The topical drug delivery market is expected to grow at a CAGR of 8.9% in the forecast period. The global topical drug delivery market is projected to reach USD 317.8 billion by 2027 from USD 207.4 billion in 2022, at a CAGR of 8.9%. The growth of this market can largely be attributed to the high prevalence of topical prescription therapy for dry eye diseases,  growing focus of pharmaceutical companies on the R&D of smart transdermal drug delivery systems, increase in prevalence of central nervous disorders,  rising preference for non-invasive drug delivery methods. “The semi-solid formulation segment accounted for the largest share of the topical drug delivery market, based on  product in 2021.” Based on products, the topical drug delivery the market is segmented into ......
 $4950

Patient Engagement Solutions Market by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User (Provider, Payer, Patients) – Global Forecast to 2027

“Patient engagement solutions market to register a CAGR of 10.0% from 2022 to 2027” The patient engagement solutions market is projected to reach USD 27.9 billion by 2027 from USD 17.3 billion in 2022, at a CAGR of 10.0% during the forecast period. The growth of this market is driven by the adoption and changes in government regulations to promote patient-centric care and involve patients throughout the care journey, high demand for patient engagement solutions, and the growing utilization of m- health apps. However, interoperability issues for patient engagement solutions and a dreadth of skilled IT professionals in the healthcare industry are expected to restrain the growth of this market during the forecast period. “Services segment is expected to grow at the highest rate......
 $4950

Healthcare Cloud Computing Market by Product (EMR/EHR, VNA, RIS, LIS, PIS), Deployment (Private Cloud, Hybrid Cloud, Public Cloud), Component (Software, Services), Pricing (Spot Pricing), Service (SaaS, IaaS, PaaS), End User – Global Forecasts to 2027

The global Healthcare cloud computing market is projected to reach USD 89.4  billion by 2027 from USD 39.4 billion in 2022, at a CAGR of 17.8%. The factors driving the market are adoption of technologies like telehealth, EHR, big data analytics, IoT, cloud computing, m health, wearlable devices, etc. “The healthcare provider solution was the largest segment in the healthcare cloud computing market in 2021.” The healthcare provider segment accounted for the larger share of 79.2% of the healthcare cloud computing market in 2021. The growing adoption of various health IT solutions such as EHR, e-prescribing, telehealth, mHealth, and others due to COVID-19 is one of the key factors contributing to the growth of this segment. “Among end users, the healthcare providers segment ac......
 $4950

Digital Pathology Market by Product (ArtificiaI Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma, Academia, Hospitals) – Global Forecast to 2026

“The Digital Pathology market is projected to grow at a CAGR of 13.2% during the forecast period (2021–2026).” The global digital pathology market is projected to reach USD 1,371 million by 2026 from USD 736 million in 2021, at a CAGR of 13.2% during the forecast period. The growth in the digital pathology market is mainly driven by factors such as the increasing adoption of digital pathology to enhance lab efficiency, rising incidence of cancer, and growing applications of digital pathology in drug development and companion diagnostics. On the other hand, the high costs of digital pathology systems are expected to restrain market growth to a certain extent. “The scanners segment accounted for the largest share of the Digital Pathology market in 2020.” Based on products,......
 $4950

Telehealth & Telemedicine Market by Component (Software & Services (RPM, Real-Time), Hardware (Monitors)), Delivery (On-Premise, Cloud-Based), Application (Teleradiology, Telestroke, TeleICU), End User (Provider, Payer) & Region – Global Forecasts to 2027

“The telehealth & telemedicine market is projected to grow at a CAGR of 26.6% during the forecast period (2022–2027).” The global telehealth & telemedicine market is expected to grow at a CAGR of 26.6% during the forecast period, to reach USD 285.7 billion by 2027 from an estimated USD 87.8 billion in 2022.The key factors driving the growth of this market include the need to expand healthcare access, the growing prevalence of chronic diseases and conditions, a shortage of physicians, advancements in telecommunications, government support and raising awareness, and rising technology adoption in the wake of COVID-19. However, regional variations in regulations, fraud, and the use of social media for care providers will restrict the market growth during the forecast period. ......
 $4950

Teleradiology Market by Product & Service (Services, Hardware, Software (PACS, RIS)), Imaging Technique (MRI, CT, X-ray, Ultrasound, Mammography, Nuclear Imaging), End User (Hospitals, Diagnostic Centers& Laboratories), COVID-19 Impact – Forecast to 2026

“A shortage of skilled radiologists & need for faster and improved diagnosis are driving market growth” The teleradiology market is expected to reach USD 14.8billion by 2026 from USD 7.3 billion in 2021, at a CAGR of 15.3% during the forecast period of 2021 to 2026. Due to the outbreak of coronavirus globally, there is a sudden rise in the demand for teleradiology services. The growth of this market is mainly attributed to the growth of the teleradiology market is driven by the rising geriatric population and the subsequent increase in the prevalence of associated diseases; the increasing number of advanced imaging procedures and a shortage of skilled radiologists; advancements in teleradiology the increasing adoption of cloud-based solutions. However, declining reimbursements a......
 $4950

Healthcare Consulting Services Market by Type of Service (Digital Health, IT, Operations, Strategy, Financial, HR & Talent), End User (Government Bodies, Healthcare Providers, Pharmaceutical & Biotechnology Companies), and Region – Global Forecasts to 2026

Global healthcare consulting services market is projected to grow at CAGR of 11.5%” The global healthcare consulting services market is projected to reach USD 41.2 billion by 2026 from USD 23.9 billion in 2021, at a CAGR of 11.5% during the forecast period. Healthcare consulting firms specialize in providing business consulting services to the healthcare industry in areas such as finance, accounting, marketing, insurance, healthcare management, billing, coding, regulations & compliance, healthcare standards, and many other similar areas. Growth in the healthcare consulting services market can be primarily attributed to the growing budget cuts, increasing pricing pressure, changing healthcare policies/regulations, and rising technological disruption across the healthcare industry t......
 $4950

Animal Growth Promoters and Performance Enhancers Market by Type (Antibiotic and Non-antibiotic (Hormones, Acidifiers, Feed Enzymes, Probiotics & Prebiotics, Phytogenic)), Animal Type (Poultry, Porcine, Livestock, Aquaculture) – Global Forecast to 2026

“The global animal growth promoters and performance enhancers market is projected to grow at a CAGR of 5.7%” The global animal growth promoters and performance enhancers market is projected to reach USD 21.4 billion by 2026 from USD 16.2 billion in 2021, at a CAGR of 5.7%. Animal health products, including growth promoters and performance enhancers, are types of drugs and chemicals used for animal growth. These enhancers help to digest food more effectively and enable animals to grow faster, which, in turn, help to improve productivity. Growth in the animal growth promoters and performance enhancers market is majorly driven by the rising demand for animal consumption and consumption of livestock-based products, rising global demand for naturally produced growth promoters, and rising......
 $4950

Hemophilia A and B – Epidemiology Forecast to 2030

Hemophilia A and B - Epidemiology Forecast to 2030 Summary Hemophilia is an X-linked hereditary bleeding disorder characterized by impaired blood coagulation because of deficiencies in the production or function of coagulation factor VIII in hemophilia A or factor IX in hemophilia B (Bolton-Maggs and Pasi, 2003). Because of the deficiency of coagulation factor, hemophilia patients have a tendency to bleed in joints, muscles, soft tissues, and within mucous membranes, which can be either spontaneous or due to internal or external trauma, depending on the severity of the disease (CDC, 2021; Mayo Clinic, 2021). According to the World Federation of Hemophilia (WFH), hemophilia is rare. About 1 in 10,000 people are born with hemophilia A and about 1 in 50,000 people are born with hemophilia B......
 $3995
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy